Risk factors associated with major cerebrovascular complications after intracranial stenting

Neurology

Volumn 72, Issue 23, 2009, Pages 2014-2019

  Nahab, F ^a,j   Lynn, M J ^a   Kasner, S E ^b   Alexander, M J ^c   Klucznik, R ^d   Zaidat, O O ^e   Chaloupka, J ^f   Lutsep, H ^g   Barnwell, S ^g   Mawad, M ^h   Lane, B ^a   Chimowitz, M I ⁱ  

^a EMORY UNIVERSITY   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d HOUSTON METHODIST HOSPITAL   (United States)

^e MEDICAL COLLEGE OF WISCONSIN   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j Building A ^*  (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN;

ADULT; ARTERY OCCLUSION; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN ISCHEMIA; BRAIN SURGERY; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; DEATH; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RISK FACTOR; STENT; TRANSIENT ISCHEMIC ATTACK;

EID: 67649472551     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/01.wnl.0b013e3181a1863c     Document Type: Article

References (26)

1. Sacco RL, Kargman DE, Gu Q, et al. Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. Stroke 1995;26:14-20.
2. Broderick J, Brott T, Kothari R, et al. The Greater Cincinnati/ Northern Kentucky Stroke Study: preliminary firstever and total incidence rates of stroke among blacks. Stroke 1998;29:415-421.
3. Wityk RJ, Lehman D, Klag M, et al. Race and sex differences in the distribution of cerebral atherosclerosis. Stroke 1996;27:1974-1980.
4. Wong KS, Huang YN, Gao S, et al. Intracranial stenosis in Chinese patients with acute stroke. Neurology 1998;50: 812-813.
5. Kasner SE, Chimowitz MI, Lynn MJ, et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006;113:555-563.
6. Gomez CR, Misra VK, Liu MW, et al. Elective stenting of symptomatic basilar artery stenosis. Stroke 2000;31:95-99.
7. Zhang QZ, Miao ZR, Li SM, et al. Complications of stent-assisted angioplasty of symptomatic intracranial artery stenosis [in Chinese]. Zhonghua Yi Xue Za Zhi 2003; 83:1402-1405.
8. Jiang WJ, Du B, Wang YJ, et al. Symptomatic intracranial artery stenosis: angiographic classifications and stentassisted angioplasty [in Chinese]. Zhonghua Nei Ke Za Zhi 2003;42:545-549.
9. de Rochemont M, Turowski B, Buchkremer M, et al. Recurrent symptomatic high-grade intracranial stenoses: safety and efficacy of undersized stents: initial experience. Radiology 2004;231:45-49.
10. Liu JM, Hong B, Huang QH, et al. Safety and short-term results of stent-assisted angioplasty for the treatment of intracranial arterial stenosis [in Chinese]. Zhonghua Yi Xue Za Zhi 2004;42:169-172.
11. Jiang WJ, Wang YJ, Du B, et al. Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004;35:1375-1380.
12. Lylyk P, Vila JF, Miranda C, et al. Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 2005;27 (suppl 1):S84-S88.
13. Kim DJ, Lee BH, Kim DI, et al. Stent-assisted angioplasty of symptomatic intracranial vertebrobasilar artery stenosis: feasibility and follow-up results. AJNR Am J Neuroradiol 2005;26:1381-1388.
14. Lee CY, Yim MB. Primary stent therapy for symptomatic intracranial atherosclerotic stenosis: 1-year follow-up angiographic and midterm clinical outcomes. J Neurosurg 2006;105:235-241.
15. Jiang WJ, Xu XT, Du B, et al. Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis. Neurology 2007;68:856-858.
16. Freitas JM, Zenteno M, Aburto-Murrieta Y, et al. Intracranial arterial stenting for symptomatic stenoses: a Latin American experience. Surg Neurol 2007;68:378-386.
17. Zaidat OO, Klucznik R, Alexander MJ, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology 2008;70:1518-1524.
18. Levy EI, Horowitz MB, Koebbe CJ, et al. Transluminal stent-assisted angioplasty of the intracranial vertebrobasilar system for medically refractory, posterior circulation ischemia: early results. Neurosurgery 2001;48:1215-1223.
19. Levy EI, Hanel RA, Bendok BR, et al. Staged stent-assisted angioplasty for symptomatic intracranial vertebrobasilar artery stenosis. J Neurosurg 2002;97:1294-1301.
20. SSYL VIA Study Investigators. Stenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study results. Stroke 2004;35:1388-1392.
21. Jiang WJ, Srivastava T, Gao F, et al. Perforator stroke after elective stenting of symptomatic intracranial stenosis. Neurology 2006;66:1868-1872.
22. Wennberg DE, Lucas FL, Birkmeyer JD, et al. Variation in carotid endarterectomy mortality in the Medicare population. JAMA 1998;279:1278-1281.
23. Cebul RD, Snow RJ, Pine R, et al. Indications, outcomes and provider volumes for carotid endarterectomy. JAMA 1998;279:1282-1287.
24. Karp HR, Flanders WD, Shipp CC, et al. Carotid endarterectomy among Medicare beneficiaries. Stroke 1998;29: 46-52.
25. Lin PH, Bush RL, Peden EK, et al. Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome. Am J Surg 2005;190:850-857.
26. Verzini F, Cao P, De Rango P, et al. Appropriateness of learning curve for carotid artery stenting: an analysis of periprocedural complications. J Vasc Surg 2006;44:1205- 1212.